Global medical diagnostics firm Randox’s operations in India have recently achieved registration to both ISO 13485: 2003 and EN ISO 13485:2012 for the manufacture of medical devices. The registrations were awarded by BSI Group India and covers the filing, packaging, labelling and distribution of in vitro diagnostic test kits, reagents and analysers.
Brian Walsh, Head, Randox India said, “Our achievement of these registrations is evidence that Indian confidence and loyalty in the Randox brand continues to grow. We are excited for our future here, and for how we can contribute to healthcare in India.”
“We are therefore delighted to have been recognised for our standards in India. Manufacturing to quality management standards such as ISO 13485: 2003 and EN ISO 13485:2012 also reinforces the confidence that our customers across India have in Randox and our products. As one of the world’s major growth economies, the scale of the market means there is always room for new business opportunities and we hope that these opportunities continue to grow,” he added.
EH News Bureau
- Advertisement -
